One patent currently held, every record listed here
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2043. from the record
Of the 1 now held by other companies, 1 name National University Corporation Kagawa University as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2043
Next term end
1
Patent families
When these terms end
Each bar runs from grant to computed term end. 2016 to 2043.
US 9,237,744
Preservative Solution for Cells, Tissues and Organs Containing Rare Sugar and Preservative Method thereof
May 20, 2032
US 12,503,480
Cyclic Phosphazene Compound Having Oxaphosphorin Ring-Containing Structure
Jan 8, 2043
20222028203420402043
2 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends May 2032 · High confidence
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2032.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Cyclic Phosphazene Compound Having Oxaphosphorin Ring-Containing Structure | 1 in force | to Jan 2043 |
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,503,480 | Cyclic Phosphazene Compound Having Oxaphosphorin Ring-Containing Structure In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 1 patent in force now held by others · 3 patents ended · 2 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.